generics

Sun's profit crushed as it pays $150M to settle Provigil pay-for-delay case
Sun's profit crushed as it pays $150M to settle Provigil pay-for-delay case
Fierce Pharma
Sun Pharma
Provigil
pay-for-delay
generics
Mylan Labs
Flag link:
Teva kept quiet for weeks on forthcoming generics blow: report
Teva kept quiet for weeks on forthcoming generics blow: report
Fierce Pharma
Teva Pharmaceutical
generics
Flag link:
Mylan points finger at FDA for failure to win nods on Advair, Copaxone copies
Mylan points finger at FDA for failure to win nods on Advair, Copaxone copies
Fierce Pharma
Mylan Labs
FDA
Advair
Copaxone
generics
Teva Pharmaceutical
GSK
Flag link:
Spurred by Gottlieb, FDA on track to the most generic drug OKs ever in 1 year
Spurred by Gottlieb, FDA on track to the most generic drug OKs ever in 1 year
Endpoints
FDA
generics
Scott Gottlieb
Flag link:
Mylan, like other generic drugmakers, feels the pricing pain
Mylan, like other generic drugmakers, feels the pricing pain
Stat
Mylan Labs
generics
drug pricing
Flag link:
FDA's generic competition push hits Valeant's Isuprel, a price-hike poster child
FDA's generic competition push hits Valeant's Isuprel, a price-hike poster child
Fierce Pharma
FDA
generics
Valeant Pharmaceuticals
Isuprel
drug pricing
nexus
Flag link:
Gottlieb: FDA to Issue new Policies to Streamline Generic Reviews in 2017
Gottlieb: FDA to Issue new Policies to Streamline Generic Reviews in 2017
RAPS.org
FDA
generics
Scott Gottlieb
Flag link:
With appeals court win, Takeda scores blockbuster Velcade patent reprieve till 2022
With appeals court win, Takeda scores blockbuster Velcade patent reprieve till 2022
Fierce Pharma
Takeda
Velcade
patents
generics
Flag link:
Biotech Movers: Impax Shares Jump on FDA Approval for Generic Version of Concerta
Biotech Movers: Impax Shares Jump on FDA Approval for Generic Version of Concerta
TheStreet.com
biotech
Impax Labs
FDA
generics
Concerta
ADHD
Flag link:
Novartis stocks drug cabinet with "Big-3" arthritis blockbusters
Novartis stocks drug cabinet with "Big-3" arthritis blockbusters
Yahoo/Reuters
Novartis
rheumatoid arthritis
generics
Sandoz
Amgen
Enbrel
JNJ
Remicade
AbbVie
Humira
Flag link:
Lilly fends off Cialis generics with new patent settlement
Lilly fends off Cialis generics with new patent settlement
Fierce Pharma
Eli Lilly
Cialis
generics
patents
erectile dysfunction
Flag link:
Facing a critical August deadline, House passes bill to reauthorize FDA user fee programs
Facing a critical August deadline, House passes bill to reauthorize FDA user fee programs
Endpoints
FDA
user fees
generics
devices
biosimilars
Flag link:
Teva accuses former executive of siphoning trade secrets to her rival CEO boyfriend
Teva accuses former executive of siphoning trade secrets to her rival CEO boyfriend
Fierce Pharma
Teva Pharmaceuticals
trade secrets
Apotex
generics
Flag link:
FDA Speeding Generic Drug Approvals: Not Just Lip Service
FDA Speeding Generic Drug Approvals: Not Just Lip Service
RAPS.org
FDA
generics
drug approvals
Scott Gottlieb
Flag link:
Generic drug association sues to stop state price-gouging law
Generic drug association sues to stop state price-gouging law
BioPharma Dive
generics
drug pricing
price gouging
Association for Accessible Medicines
Maryland
Flag link:
Generic drug industry lawsuit blasts Maryland pricing law as 'unconstitutional and invalid'
Generic drug industry lawsuit blasts Maryland pricing law as 'unconstitutional and invalid'
Fierce Pharma
generics
Maryland
drug pricing
Flag link:
Pfizer Exits Brazil Venture
Pfizer Exits Brazil Venture
TheStreet.com
Pfizer
Brazil
Laboratorio Teuto Brasileiro S.A
generics
Flag link:
Biogen aims to block Tecfidera generics with flurry of lawsuits
Biogen aims to block Tecfidera generics with flurry of lawsuits
Bizjournals.com
Biogen
Tecfidera
generics
MS
multiple sclerosis
Novartis
Sandoz
Mylan Labs
Flag link:
FDA's first steps in drug competion plan: get more generics approved
FDA's first steps in drug competion plan: get more generics approved
BioPharma Dive
FDA
competition
generics
Scott Gottlieb
Flag link:
Price-hike king Valeant could be hit hardest by FDA generics push: analyst
Price-hike king Valeant could be hit hardest by FDA generics push: analyst
Fierce Pharma
Valeant Pharmaceuticals
FDA
generics
drug pricing
Flag link: